杜邦2026年业务重组与财务指引关键事件前瞻

Core Viewpoint - DuPont is focusing on business restructuring and financial guidance execution in 2026, which includes the sale of its aramid business and achieving annual performance targets [1]. Recent Events - The sale of the aramid business has been completed, with DuPont announcing in August 2025 that it would sell its aramid business (including Nomex and Kevlar brands) to TJC's subsidiary Arclin for a total estimated value of approximately $1.8 billion. The transaction is expected to be completed by the end of the first quarter of 2026 (around the end of March 2026), further simplifying the company's business structure and allowing it to focus on core areas [2]. Performance and Operations - For 2026, the company has provided guidance in its Q4 2025 financial report, expecting adjusted earnings per share to be between $2.25 and $2.30, with net sales projected to be between $7.08 billion and $7.14 billion. The market will closely monitor quarterly reports (such as the Q1 2026 report) to assess whether these targets are met and to evaluate the growth trajectory of the core business post-restructuring [3]. Strategic Advancement - The ongoing strategic restructuring is impacting DuPont as it divests non-core businesses (such as the electronic business spin-off completed in November 2025) to focus on healthcare and water technology sectors. Future cash flows may be directed towards research and development investments or shareholder returns, such as a $2 billion stock buyback plan and a quarterly dividend of $0.20 per share. The long-term effects of these initiatives will be a focal point [4].